Pharma companies have announced a major reduction in their R&D budgets in the coming years. What repercussions will it create on the pharma industry? Increasing R&D productivity was the unanimous reason given out by the heads of these companies
The overall compound annual growth rate of the pharmaceutical market (2009-2013), for its part, is projected to be 24%, with the market reaching an estimated $73 billion by 2013
The US Senate has voted on November 22 to open a full-fledged debate on President Barack Obamas most ambitious plan to overhaul the nations healthcare system which will cost more than $ 1.2 tn in the next 10 years
